Companion Biomarker and Therapeutic Strategy Development for Pancreatic Cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1056012

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Innovation of predictive and responsive biomarkers in pancreatic cancer (PC) is of paramount importance. This project contains two parts: 1. Circulating DNA. It has been shown previously that DNA released into the blood stream by cancer can be measured, its usefulness in PC will be assessed. 2. ROCK-I as a predictive biomarker. ROCK-I is a protein involved in cell motility. The ability for ROCK-I amplification to predict for response to ROCK-I inhibitors will be assessed in vitro/in vivo.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Postgraduate Scholarships

Funding Amount: $121,031.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Molecular Targets

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | cancer chemotherapeutic agents | cancer genetics | pancreatic cancer

Related Links